Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Mycapssa (octreotide)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Chiesi

Drug class:

SSTR agonist

Related drugs:

No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	prednisone Sensitive: A2 - Guideline prednisone Sensitive : A2	prednisone Sensitive: A2 - Guideline prednisone Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	prednisone Sensitive: A2 - Guideline prednisone Sensitive : A2	prednisone Sensitive: A2 - Guideline prednisone Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Neuroendocrine Tumor	No biomarker	Neuroendocrine Tumor	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
SSTR positive	Neuroendocrine Tumor	SSTR positive	Neuroendocrine Tumor	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
SSTR5 expression	Neuroendocrine Tumor	SSTR5 expression	Neuroendocrine Tumor	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
SSTR2 expression	Neuroendocrine Tumor	SSTR2 expression	Neuroendocrine Tumor	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
SSTR5 expression	Non Small Cell Lung Cancer	SSTR5 expression	Non Small Cell Lung Cancer	paclitaxel Sensitive: D – Preclinical paclitaxel Sensitive : D	paclitaxel Sensitive: D – Preclinical paclitaxel Sensitive : D
SSTR2 expression	Non Small Cell Lung Cancer	SSTR2 expression	Non Small Cell Lung Cancer	paclitaxel Sensitive: D – Preclinical paclitaxel Sensitive : D	paclitaxel Sensitive: D – Preclinical paclitaxel Sensitive : D